Utah People's Post

The Latest News from the Beehive State

Wednesday, February 1, 2023
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / FDA advisory panel recommends two new antibiotics Dalvance, Sivextro

FDA advisory panel recommends two new antibiotics Dalvance, Sivextro

April 1, 2014 Posted by Contributor

The advisory committee of US Food and Drug Administration (FDA) has given its nod to two new antibiotics Durata Therapeutics’s Dalvance and Cubist Pharmaceuticals’s Sivextro.

The anti-infective drugs advisory committee of FDA unanimously recommended the approval of two new antibiotics on Monday.

One of the panel member Thomas A. Moore said, “It’s (Dalvance) a highly effective drug, as demonstrated in the trial.”

Moore is a clinical professor of medicine at the University of Kansas School of Medicine.

101005496-f62eaa6f894e6bc223700f66d9354e18208e8db0.530x298

According to the experts, the FDA is giving speeded approval to new antibiotics as there is a huge need of new drugs that can combat infections that are resistant to existing drugs.

A U.S. Centers for Disease Control report says, an estimated 23,000 Americans alone die from such infections annually and millions more get sick from them.

The drugs the panel recommended Monday weren’t studied entirely, or even primarily, in drug-resistant infections, such as multidrug-resistant tuberculosis, a scourge throughout much of the world.

Edward Cox, chief of the FDA’s division of antimicrobial drugs, said, “The acute bacterial skin conditions for which the news drugs-Dalvance and Sivextro- are intended are potentially lethal and that it is important for doctors to have more than one treatment option.”

Durata Therapeutics’s CEO Paul Edick said in a statement, “We are pleased with the positive outcome of Advisory Committee meeting, and the confidence that was expressed regarding the safety and effectiveness of Dalvance. If approved by the FDA, Dalvance would be the first once-weekly antibiotic for ABSSSI, providing an alternative to current once- or twice-daily treatments. We look forward to continuing to work with the FDA on its evaluation of our product.”

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health Tagged With: antibiotics, Cubist Pharmaceuticals, Dalvance, Durata Therapeutics, FDA, Sivextro, US Food and Drug Administration

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

    Jun 29, 2018
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

    Jun 29, 2018
  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

    Jun 27, 2018
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

    Jun 25, 2018
  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

    Jun 22, 2018
  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

    Jun 21, 2018
  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

    Jun 19, 2018
  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

    Jun 18, 2018
  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

    Jun 15, 2018
  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

    Jun 13, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2023 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact